1. Home >
  2. Companies >
  3. PE Backed >
  4. Life Science >
  5. SERB Pharmaceuticals >
  6. M&A

SERB Pharmaceuticals Mergers & Acquisitions

SERB Pharmaceuticals M&A Summary

SERB Pharmaceuticals has acquired 3 companies of its own, including 3 in the last 5 years.

SERB Pharmaceuticals’ largest acquisition to date was in 2020, when it acquired BTG Specialty Pharmaceuticals for $800M. SERB Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include life science (67%) and medical products (34%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

SERB Pharmaceuticals

SERB S.a.r.l.

8 rue Beaumont,
Luxembourg, 1219
Luxembourg,
+352 26 20 12 16
www.serb.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-08-05 Y-mAbs Therapeutics · Life Science
Princeton, New Jersey · www.ymabs.com

Y-mAbs Therapeutics is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. With a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets. Y-mAbs Therapeutics was founded in 2015 and is based in Princeton, New Jersey.

Revenue (mlns) 88 USD
Advisors: Centerview Partners , Cooley , Wilkinson Barker Knauer 		412
4.7x REVENUE 		Add-on Acquisition

SERB Pharmaceuticals
Advisors: Freshfields Bruckhaus Deringer , Rothschild Global Advisory

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal